KRAS and malignant colon neoplasm: This agent has induced extensive cytotoxicity in human models of colon cancer [21-23], suggesting that GLI is a critical target in colon cancer cell survival, and in other cancers where GLI is constitutively activated and/or an oncogenic KRAS-GLI axis drives proliferation.